Daily Cosmetic Research Analysis
Three advances stand out today: a yeast-based platform that systematically expands isoprenoid chemical space for fragrances, actives, and cannabinoids; a sustainable metal-phenolic nanocellulose system that stabilizes antioxidants and protects reconstructed human skin from UV-induced oxidative stress; and an animal-free next-generation risk assessment of a hair dye focused on hepatic steatosis using AOP-guided in vitro testing and quantitative dose–response modeling.
Summary
Three advances stand out today: a yeast-based platform that systematically expands isoprenoid chemical space for fragrances, actives, and cannabinoids; a sustainable metal-phenolic nanocellulose system that stabilizes antioxidants and protects reconstructed human skin from UV-induced oxidative stress; and an animal-free next-generation risk assessment of a hair dye focused on hepatic steatosis using AOP-guided in vitro testing and quantitative dose–response modeling.
Research Themes
- Synthetic biology expands isoprenoid analogs for cosmetic and pharmaceutical applications
- Sustainable antioxidant delivery via metal-phenolic nanocellulose for skin protection
- Animal-free next-generation risk assessment (NGRA) for cosmetic hair dye safety
Selected Articles
1. Systematic biotechnological production of isoprenoid analogs with bespoke carbon skeletons.
The authors present a yeast-based biocatalytic platform that systematically introduces extra carbons into diverse isoprenoid classes, enabling production of analogs with tailored properties. Proof-of-concept includes biosynthesis of ethyllinalool and cannabinoid analogs with enhanced receptor agonism, highlighting broad utility for fragrance and bioactive discovery.
Impact: This is a platform technology that expands chemical space across multiple natural product classes, directly impacting fragrance and cosmetic ingredient development while enabling structure–activity exploration at scale.
Clinical Implications: While preclinical, this approach accelerates access to novel fragrance and bioactive candidates with potentially improved safety or efficacy profiles, informing dermatology-adjacent product pipelines (e.g., topical actives) and precision formulation.
Key Findings
- Developed a yeast cell-based method to produce isoprenoid analogs (monoterpenoids, sesquiterpenoids, triterpenoids, cannabinoids) with additional carbon atoms.
- Demonstrated biosynthesis of ethyllinalool and cannabinoid analogs exhibiting improved cannabinoid receptor agonism.
- Platform is simple, adaptable to diverse cell factories, and expands isoprenoid chemical space to identify molecules with improved properties.
Methodological Strengths
- Cross-class demonstration with two proof-of-concept case studies.
- Modular, cell-factory-adaptable biocatalytic workflow enabling reproducibility and scalability.
Limitations
- Primarily preclinical with limited in vivo validation of analog safety/efficacy.
- Manufacturing economics and regulatory pathways for novel analogs remain to be defined.
Future Directions: Integrate cheminformatics-guided design and high-throughput screening to prioritize analogs with superior dermatologic and safety profiles; evaluate scale-up fermentation and downstream purification for industrial deployment.
Natural products are widely used as pharmaceuticals, flavors, fragrances, and cosmetic ingredients. Synthesizing and evaluating analogs of natural products can considerably expand their applications. However, the chemical synthesis of analogs of natural products is severely hampered by their highly complex structures. This is particularly evident in isoprenoids, the largest class of natural products. Here, we develop a yeast cell-based biocatalytic method that enables the systematic biotechnological production of analogs of different classes of isoprenoids (including monoterpenoids, sesquiterpenoids, triterpenoids, and cannabinoids) with additional carbons in their skeletons. We demonstrate the applicability of this approach through two proof-of-concept studies: the biosynthesis of the highly valued aroma ingredient ethyllinalool, and the production of cannabinoid analogs with improved cannabinoid receptor agonism. This method is simple, readily adaptable to any cell factory, and enables the tailored expansion of the isoprenoid chemical space to identify molecules with improved properties and the biotechnological production of valuable compounds.
2. Metal-Phenolic Networks Enable Biomimetic Antioxidant Interfaces Through Nanocellulose Engineering.
The study introduces an MPN-coated, carboxylated nanocellulose Pickering emulsion that stabilizes oxidation-sensitive actives. It retains α-tocopherol (94% over 50 days), reduces cellular ROS by 80%, and mitigates UV-induced damage in reconstructed human skin, suggesting a sustainable alternative to synthetic antioxidant systems for topical formulations.
Impact: Provides a biocompatible, sustainable interface technology with demonstrated efficacy in skin models, directly informing cosmetic and dermatologic formulation strategies for photoprotection and anti-aging.
Clinical Implications: Supports development of topical products with improved antioxidant stability and efficacy, potentially reducing UV-induced dermal damage and enhancing stratum corneum integrity without relying on synthetic stabilizers.
Key Findings
- MPN-decorated carboxyl-functionalized cellulose nanofibers form a stable antioxidant Pickering emulsion validated by DLVO modeling and rheology.
- Achieved 94% α-tocopherol retention over 50 days and an 80% reduction in cellular ROS.
- In reconstructed human skin, preserved stratum corneum integrity and suppressed UV-induced MMP-1 expression.
Methodological Strengths
- Multiscale validation (theoretical DLVO modeling, rheology, cellular assays, reconstructed human skin).
- Clear, quantifiable performance metrics (α-tocopherol retention, ROS reduction, MMP-1 suppression).
Limitations
- Lacks clinical (in vivo) testing on human subjects.
- Long-term safety and compatibility across diverse actives and formulations remain to be established.
Future Directions: Evaluate performance with broader active payloads, conduct human patch/clinical studies for efficacy and tolerability, and assess manufacturability at scale with life-cycle sustainability metrics.
Metal-phenolic networks (MPNs) integrated with functionalized cellulose nanofibers present a promising platform for stabilizing oxidation-sensitive compounds. Here, a novel antioxidant pickering emulsion system utilizing MPN-decorated carboxyl-functionalized pulp cellulose nanofibers (MPN-PCNF) is demonstrated. The system exhibits exceptional interfacial stability through synergistic effects of MPN coating and alkyl functionalization, validated by DLVO theoretical modeling and rheological characterization. MPN-PCNF demonstrates remarkable antioxidant efficacy, achieving 94% α-tocopherol retention over 50 days and 80% reduction in cellular reactive oxygen species. In reconstructed human skin models, the system significantly attenuates UV-induced oxidative stress, evidenced by preserved stratum corneum integrity and suppressed matrix metalloproteinase-1 expression. This biocompatible platform represents a versatile solution for protecting oxidation-sensitive compounds across pharmaceutical, cosmetic, and food applications, offering a sustainable alternative to conventional synthetic antioxidant systems.
3. Next generation risk assessment of hair dye HC yellow no. 13: Ensuring protection from liver steatogenic effects.
Using an animal-free NGRA framework, the authors focused on hepatic steatosis as a key mode of action for a hair dye flagged by in silico tools. Human stem cell-derived hepatocytes showed gene expression changes across lipid metabolism pathways and triglyceride accumulation, enabling derivation of in vitro PoDs via PROAST to inform dermal safety margins.
Impact: Demonstrates a practical, human-relevant NGRA pipeline for cosmetic ingredients, aligning with global moves away from animal testing and providing quantitative PoDs for regulatory decision-making.
Clinical Implications: Supports safer formulation and regulatory submissions for hair dyes by quantifying steatogenic risk using human-relevant assays, enabling dermatologists and toxicologists to better counsel on product safety.
Key Findings
- Adopted an AOP-guided NGRA focusing on hepatic steatosis for HC Yellow No. 13 due to in silico hepatotoxic alerts.
- In human stem cell-derived hepatocytes, measured expression of 11 lipid metabolism genes and triglyceride accumulation after 72 h exposure.
- Derived in vitro Points of Departure (PoDs) using PROAST to inform protective dermal exposure limits.
Methodological Strengths
- AOP-guided testing strategy with human stem cell-derived hepatic model relevant to the target organ.
- Quantitative benchmark modeling (PROAST) to derive Points of Departure from multiple endpoints.
Limitations
- In vitro findings may not fully capture systemic metabolism and exposure dynamics.
- No confirmatory human exposure or epidemiological data presented.
Future Directions: Integrate in vitro-to-in vivo extrapolation (IVIVE) and dermal PBPK modeling to translate PoDs to consumer exposure scenarios; expand AOP endpoints to include mitochondrial dysfunction and inflammation pathways.
This study employs animal-free Next Generation Risk Assessment (NGRA) principles to evaluate the safety of repeated dermal exposure to 2.5% (w/w) HC Yellow No. 13 (HCY13) hair dye. As multiple in silico tools consistently flagged hepatotoxic potential, likely due to HCY13's trifluoromethyl group, which is known to interfere with hepatic lipid metabolism, liver steatosis was chosen as the primary mode of action for evaluation. AOP-guided in vitro tests were conducted, exposing human stem cell-derived hepatic cells to varying HCY13 concentrations over 72 h. The expression of 11 lipid metabolism-related marker genes (AHR, PPARA, LXRA, APOB, ACOX1, CPT1A, FASN, SCD1, DGAT2, CD36, and PPARG) and triglyceride accumulation, a phenotypic hallmark of steatosis, were measured. PROAST software was used to calculate in vitro Points of Departure (PoD